Fractionation of amyloid β-protein (Aβ) in Alzheimer's disease and down's syndrome brains: Presence of membrane-bound Aβ

Annals of the New York Academy of Sciences

Volumn 786, Issue , 1996, Pages 184-194

  Yanagisawa, Katsuhiko ^a   Asami Odaka, Asano ^b   Suzuki, Nobuhiro ^b   Ihara, Yasuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN; BRAIN CORTEX; CONFERENCE PAPER; DOWN SYNDROME; FRACTIONATION; IMMUNOBLOTTING; IMMUNOREACTIVITY; NEUROPATHOLOGY;

EID: 0029741139     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb39061.x     Document Type: Article

References (18)

1. MULLANN, M. & F. CRAWFORD. 1993. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16: 398-403.
2. SELKOE, D. J. 1994. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10: 373-403.
3. KANG, J. et al. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
4. MORI, H., K. TAKIO, M. OGAWARA & D. J. SELKOE. 1992. Mass spectrometry of purified amyloid β-protein in Alzheimer's disease. J. Biol. Chem. 267: 17082-17086.
5. ROHER, A. E. et al. 1993. Structural alteration in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268: 3072-3083.
6. HAASS, C. et al. 1992. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
7. SEUBERT, P. et al. 1992. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature. 359: 325-327.
8. SHOJI, M. et al. 1992. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258: 126-129.
9. IWATSUBO, T. et al. 1994. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13: 45-53.
10. SUZUKI, N. et al. 1994. High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145: 452-460.
11. SUZUKI, N. et al. 1994. An increased percentage of long amyloid β-protein is secreted by familial amyloid β-protein precursor (βAPP717) mutants. Science 264: 1336-1340.
12. LAEMMLI, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
13. PAN, B-T. & R. M. JOHNSTONE. 1983. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33: 967-977.
14. HOLLOSI, M., L. OTVOS, JR., J. KAJTAR, A. PERCEL & V. M-Y. LEE. 1989. Is amyloid deposition in Alzheimer's disease preceded by an environment-induced double conformational transition? Pep. Res. 2: 109-113.
15. BARROW, C. J. & M. G. ZAGORSKI. 1991. Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253: 179-182.
16. OTVOS, L., JR., G. I. SZENDREI, V. M-Y. LEE & H. H. MANTSCH. 1993. Human and rodent Alzheimer β-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur. J. Biochem. 211: 249-257.
17. TERZI, E., G. HOLZEMANN & J. SEELIG. 1994. Alzheimer β-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry 33: 7434-7441.
18. SHERRINGTON, R. et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760.